{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:04:22Z","timestamp":1790075062744,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12325-022-02096-3","type":"journal-article","created":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T13:04:05Z","timestamp":1650114245000},"page":"2796-2805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["\u201cI Can\u2019t Take off My Shirt or Do My Own Hair\u201d\u2014A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva\u00a0(FOP)"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-2995","authenticated-orcid":false,"given":"Jessica T.","family":"Markowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Rofail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Vandenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Baldasaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Pignolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Keen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Marquis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,16]]},"reference":[{"issue":"2","key":"2096_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.29245\/2572-9411\/2020\/2.1196","volume":"5","author":"M Liljesthr\u00f6m","year":"2020","unstructured":"Liljesthr\u00f6m M, Pignolo R, Kaplan F. Epidemiology of the global fibrodysplasia ossificans progressiva (FOP) community. J Rare Dis Res Treat. 2020;5(2):31\u20136.","journal-title":"J Rare Dis Res Treat"},{"issue":"1","key":"2096_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01983-2","volume":"16","author":"RJ Pignolo","year":"2021","unstructured":"Pignolo RJ, et al. Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization. Orphanet J Rare Dis. 2021;16(1):1\u20138.","journal-title":"Orphanet J Rare Dis"},{"key":"2096_CR3","unstructured":"International Fibrodysplasia Ossificans Progressiva Association (IFOPA). What is FOP?. https:\/\/www.ifopa.org\/what_is_fop. Accessed 10 July 2020."},{"issue":"2","key":"2096_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5348\/ijcri-2013-02-274-CR-8","volume":"4","author":"MS Jha","year":"2013","unstructured":"Jha MS, Shanker RV, Kumar A, Singh TB. Psychological interventions in a case of fibrodysplasia ossificans progressiva: A case report. Int J Case Rep Images (IJCRI). 2013;4(2):115\u20139.","journal-title":"Int J Case Rep Images (IJCRI)"},{"issue":"3","key":"2096_CR5","doi-asserted-by":"publisher","first-page":"A65","DOI":"10.1016\/j.jval.2015.03.954","volume":"18","author":"MS Mattera","year":"2015","unstructured":"Mattera MS, Kaplan FS, Pignolo RJ, Grogan D, Revicki DA. Patient-reported physical function outome measure for adults with fibrodysplasia ossificans progressiva: intelligent test design based on promis item banks. Value Health. 2015;18(3):A65.","journal-title":"Value Health."},{"key":"2096_CR6","first-page":"320","volume-title":"Finding magic mountain: life with five glorious kids and a rogue gene called FOP","author":"C Zapata-Whelan","year":"2006","unstructured":"Zapata-Whelan C. Finding magic mountain: life with five glorious kids and a rogue gene called FOP. Da Capo Lifelong Books; 2006. p. 320."},{"key":"2096_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bone.2017.05.017","volume":"109","author":"IL Cali","year":"2018","unstructured":"Cali IL, Rossano L. Fibrodysplasia ossificans progressiva: the patient voice. Bone. 2018;109:291\u20134.","journal-title":"Bone"},{"issue":"2","key":"2096_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jval.2016.11.014","volume":"20","author":"EM Perfetto","year":"2017","unstructured":"Perfetto EM, et al. Value to whom? The patient voice in the value discussion. Value Health. 2017;20(2):286\u201391.","journal-title":"Value Health"},{"issue":"6","key":"2096_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/bjophthalmol-2016-309955","volume":"101","author":"S Dean","year":"2017","unstructured":"Dean S, et al. \u201cThe patient is speaking\u201d: discovering the patient voice in ophthalmology. Br J Ophthalmol. 2017;101(6):700\u20138.","journal-title":"Br J Ophthalmol"},{"key":"2096_CR10","unstructured":"US Food and Drug Administration. Patient-Focused Drug Development: Collecting Comprehensive and Representative Input. Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders. 2020. https:\/\/www.fda.gov\/media\/139088\/download."},{"key":"2096_CR11","unstructured":"US Food and Drug Administration. Roadmap to Patient-Focused Outcome Measurement in Clinical Trials 2015. https:\/\/www.fda.gov\/media\/87004\/download."},{"key":"2096_CR12","unstructured":"US Food and Drug Administration. Patient-Focused Drug Development: Methods to Identify What Is Important to Patients. Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders. 2019. https:\/\/www.fda.gov\/media\/131230\/download."},{"key":"2096_CR13","volume-title":"Research methods in health: investigating health and health services","author":"A Bowling","year":"2009","unstructured":"Bowling A. Research methods in health: investigating health and health services. 3rd ed. Maidenhead: Open University Press; 2009.","edition":"3"},{"issue":"2","key":"2096_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u201390.","journal-title":"Qual Res Psychol"},{"issue":"4","key":"2096_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jval.2013.04.004","volume":"16","author":"LS Matza","year":"2013","unstructured":"Matza LS, et al. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Health. 2013;16(4):461\u201379.","journal-title":"Value Health"},{"key":"2096_CR16","unstructured":"Friese S. ATLAS. ti 7 User Manual Updated for program version: 7.5. ATLAS. ti, Berlin. 2014."},{"key":"2096_CR17","doi-asserted-by":"publisher","DOI":"10.4324\/9780203413081","volume-title":"Analyzing qualitative data","author":"A Bryman","year":"2002","unstructured":"Bryman A, Burgess B. Analyzing qualitative data. New York: Routledge; 2002."},{"issue":"2","key":"2096_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1098214005283748","volume":"27","author":"DR Thomas","year":"2006","unstructured":"Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27(2):237\u201346.","journal-title":"Am J Eval"},{"key":"2096_CR19","unstructured":"Qualitative research in health care. In: Mays N, Pope, C. editors. BMJ Books; 2000."},{"issue":"3","key":"2096_CR20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/jbmr.2728","volume":"31","author":"RJ Pignolo","year":"2016","unstructured":"Pignolo RJ, et al. The natural history of flare-ups in fibrodysplasia ossificans progressiva (FOP): a comprehensive global assessment. J Bone Miner Res. 2016;31(3):650\u20136.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2096_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.29245\/2572-9411\/2021\/1.1200","volume":"6","author":"M Al Mukaddam","year":"2021","unstructured":"Al Mukaddam M, et al. Caregiver support in fibrodysplasia ossificans progressiva. J Rare Dis Res Treat. 2021;6(1):6\u201312.","journal-title":"J Rare Dis Res Treat"},{"key":"2096_CR22","doi-asserted-by":"publisher","first-page":"115274","DOI":"10.1016\/j.bone.2020.115274","volume":"134","author":"RJ Pignolo","year":"2020","unstructured":"Pignolo RJ, et al. Self-reported baseline phenotypes from the International Fibrodysplasia Ossificans Progressiva (FOP) Association Global Registry. Bone. 2020;134:115274.","journal-title":"Bone"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02096-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02096-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02096-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T10:37:15Z","timestamp":1653043035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02096-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,16]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["2096"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02096-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,16]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}